Low ω-6/ω-3 polyunsaturated fatty acid ratios reduce hepatic C-reactive protein expression in apolipoprotein E–null mice
Abstract
Objective
Expression characteristics of C-reactive protein (CRP) for the ω-6/ω-3 polyunsaturated fatty acid (PUFA) ratios have not been evaluated in the well-qualified experimental atherosclerotic mouse model. This work focused on characteristics of CRP expression in the liver of apolipoprotein E–null (apoE−/−) mice influenced by ω-6/ω-3 PUFA ratios.
Methods
Varying ratios of ω-6/ω-3 PUFAs (group 1, 1.28; group 2, 5.03; group 3, 9.98; and group 4, 68.26, respectively) on hepatic and aortic CRP expressions were assessed in male apoE−/− mice fed a diet containing 5% (w/w) experimental fat for 6 wk. Hepatic peroxisome proliferator-activated receptor-γ mRNA abundance, hepatic interleukin (IL)-6 protein level, atherosclerotic lesions, and serum cytokines including IL-1β, IL-6, and tumor necrosis factor-α were examined.
Results
As the dietary ratio of ω-6/ω-3 fatty acids ascended, so did the expression of hepatic and aortic CRP and hepatic IL-6 protein. However, peroxisome proliferator-activated receptor-γ mRNA level had a tendency to decrease. Serum IL-1β, IL-6, and tumor necrosis factor-α levels did not show a statistical difference among the mice fed the four ratios of the ω-6/ω-3 PUFA diet. The group 4 mice developed a significant increase in atherosclerotic lesions compared with the other groups.
Conclusion
The results indicated that low ratios of ω-6/ω-3 PUFAs (1.28–9.98) downregulated the hepatic and aortic CRP expressions and reduced aortic en face lesions in apoE−/− mice compared with the high ratio of the ω-6/ω-3 PUFA diet.
Keywords: Apolipoprotein E–null mice, Atherosclerosis, C-reactive protein, Cytokine, Gene expression, Polyunsaturated fatty acid
To access this article, please choose from the options below
This work was supported by grants from the National Natural Science Foundation of China (30571024) and Science and Technology Projects of Shandong (J06L11) to Jie Pan.
PII: S0899-9007(09)00356-6
doi:10.1016/j.nut.2009.08.018
Crown Copyright © 2010. Published by Elsevier Inc. All rights reserved.
